Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hiromichi Yamane, Nobuaki Ochi, Yasunari Nagasaki, Tomoko Yamagishi, Yoshihiro Honda, Nozomu Nakagawa, Masami Takeyama, Hidekazu Nakanishi & Nagio Takigawa. (2018) Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17. Therapeutics and Clinical Risk Management 14, pages 1457-1465.
Read now
Read now
Articles from other publishers (2)
Ai Kuzumi, Ayumi Yoshizaki, Satoshi Ebata, Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Yoshihide Asano, Koji Oba & Shinichi Sato. (2021) Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease. Journal of Clinical Medicine 10:4, pages 660.
Crossref
Crossref
Yinle Lan, Shuxian Li, Dehua Yang, Junfen Zhou, Yingshuo Wang, Jianhua Wang, Yingchun Xu & Zhimin Chen. (2020) Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia. Medicine 99:19, pages e19987.
Crossref
Crossref